Long COVID and the cardiovascular system—elucidating causes and cellular mechanisms in order to develop targeted diagnostic and therapeutic strategies: a joint Scientific Statement of the ESC Working Groups on Cellular Biology of the Heart and Myocardial and Pericardial Diseases

Abstract Long COVID has become a world-wide, non-communicable epidemic, caused by long-lasting multiorgan symptoms that endure for weeks or months after SARS-CoV-2 infection has already subsided. This scientific document aims to provide insight into the possible causes and therapeutic options available for the cardiovascular manifestations of long COVID. In addition to chronic fatigue, which is a common symptom of long COVID, patients may present with chest pain, ECG abnormalities, postural orthostatic tachycardia, or newly developed supraventricular or ventricular arrhythmias. Imaging of the heart and vessels has provided evidence of chronic, post-infectious perimyocarditis with consequent left or right ventricular failure, arterial wall inflammation, or microthrombosis in certain patient populations. Better understanding of the underlying cellular and molecular mechanisms of long COVID will aid in the development of effective treatment strategies for its cardiovascular manifestations. A number of mechanisms have been proposed, including those involving direct effects on the myocardium, microthrombotic damage to vessels or endothelium, or persistent inflammation. Unfortunately, existing circulating biomarkers, coagulation, and inflammatory markers, are not highly predictive for either the presence or outcome of long COVID when measured 3 months after SARS-CoV-2 infection. Further studies are needed to understand underlying mechanisms, identify specific biomarkers, and guide future preventive strategies or treatments to address long COVID and its cardiovascular sequelae.

[1]  B. Cosyns,et al.  Subclinical myocardial dysfunction in patients with persistent dyspnea one year after COVID-19 , 2022, European Heart Journal.

[2]  H. Hedlin,et al.  Gastrointestinal symptoms and fecal shedding of SARS-CoV-2 RNA suggest prolonged gastrointestinal infection , 2022, Med.

[3]  N. Horita,et al.  Cardiac involvement in coronavirus disease 2019 assessed by cardiac magnetic resonance imaging: a meta-analysis , 2022, Heart and Vessels.

[4]  Lisa E. Gralinski,et al.  A model of persistent post SARS-CoV-2 induced lung disease for target identification and testing of therapeutic strategies , 2022, bioRxiv.

[5]  S. Efrati,et al.  Hyperbaric oxygen treatment for long coronavirus disease-19: a case report , 2022, Journal of Medical Case Reports.

[6]  Benjamin Bowe,et al.  Long-term cardiovascular outcomes of COVID-19 , 2022, Nature Medicine.

[7]  M. Hayıroğlu,et al.  Heart rate variability and cardiac autonomic functions in post-COVID period , 2022, Journal of Interventional Cardiac Electrophysiology.

[8]  B. Knechtle,et al.  What should a family physician know about nutrition and physical exercise rehabilitation’ advices to communicate to ‘long-term COVID-19’ patients? , 2022, Postgraduate medicine.

[9]  M. Puhan,et al.  Immunoglobulin signature predicts risk of post-acute COVID-19 syndrome , 2022, Nature Communications.

[10]  A. Slooter,et al.  Clinical Outcomes Among Patients With 1-Year Survival Following Intensive Care Unit Treatment for COVID-19. , 2022, JAMA.

[11]  K. Stavem,et al.  Cardiac Dysfunction and Arrhythmias 3 Months After Hospitalization for COVID‐19 , 2022, Journal of the American Heart Association.

[12]  Anchisa Kunawudhi,et al.  Abnormality Pattern of F-18 FDG PET Whole Body with Functional MRI Brain in Post-Acute COVID-19 , 2022, Nuclear Medicine and Molecular Imaging.

[13]  P. Duggal,et al.  Post‐sequelae symptoms and comorbidities after COVID‐19 , 2022, Journal of medical virology.

[14]  E. Çelik,et al.  Evaluation of 3‐month follow‐up of patients with postacute COVID‐19 syndrome , 2022, Journal of medical virology.

[15]  M. Aepfelbacher,et al.  Multi-organ assessment in mainly non-hospitalized individuals after SARS-CoV-2 infection: The Hamburg City Health Study COVID programme , 2022, European heart journal.

[16]  A. Dror,et al.  Association between vaccination status and reported incidence of post-acute COVID-19 symptoms in Israel: a cross-sectional study of patients infected between March 2020 and November 2021 , 2022, medRxiv.

[17]  V. Chaturvedi,et al.  Heart rate variability as a marker of cardiovascular dysautonomia in post-COVID-19 syndrome using artificial intelligence , 2022, Indian Pacing and Electrophysiology Journal.

[18]  Inyoul Y. Lee,et al.  Multiple early factors anticipate post-acute COVID-19 sequelae , 2022, Cell.

[19]  J. Suri,et al.  Long-COVID diagnosis: From diagnostic to advanced AI-driven models , 2022, European Journal of Radiology.

[20]  C. Tudoran,et al.  Evolution of Echocardiographic Abnormalities Identified in Previously Healthy Individuals Recovering from COVID-19 , 2022, Journal of personalized medicine.

[21]  Nelson B Rodrigues,et al.  Fatigue and cognitive impairment in Post-COVID-19 Syndrome: A systematic review and meta-analysis , 2021, Brain, Behavior, and Immunity.

[22]  K. Nadeau,et al.  Association Between SARS-CoV-2 RNAemia and Postacute Sequelae of COVID-19 , 2021, Open forum infectious diseases.

[23]  K. Chamari,et al.  General practitioners should provide the cardiorespiratory rehabilitation’ ‘minimum advice’ for long COVID-19 patients , 2021, The Libyan journal of medicine.

[24]  S. Kent,et al.  Immunological dysfunction persists for 8 months following initial mild-moderate SARS-CoV-2 infection , 2021, medRxiv.

[25]  P. Nilsson,et al.  Symptoms and Functional Impairment Assessed 8 Months After Mild COVID-19 Among Health Care Workers. , 2021, JAMA.

[26]  B. Merkely,et al.  Frequent Constriction-Like Echocardiographic Findings in Elite Athletes Following Mild COVID-19: A Propensity Score-Matched Analysis , 2022, Frontiers in Cardiovascular Medicine.

[27]  Deepak L. Bhatt,et al.  Relationship Between Myocardial Injury During Index Hospitalization for SARS‐CoV‐2 Infection and Longer‐Term Outcomes , 2021, Journal of the American Heart Association.

[28]  J. de Mey,et al.  Subclinical Myocardial Dysfunction in Patients with Persistent Dyspnea One Year after COVID-19 , 2021, Diagnostics.

[29]  K. Klingel,et al.  COVID-19 vs. Classical Myocarditis Associated Myocardial Injury Evaluated by Cardiac Magnetic Resonance and Endomyocardial Biopsy , 2021, Frontiers in Cardiovascular Medicine.

[30]  Vibha Jain,et al.  Stacking Ensemble-Based Intelligent Machine Learning Model for Predicting Post-COVID-19 Complications , 2021, New Generation Computing.

[31]  A. Ambrose,et al.  Multi‐disciplinary collaborative consensus guidance statement on the assessment and treatment of cognitive symptoms in patients with post‐acute sequelae of SARS‐CoV‐2 infection (PASC) , 2021, PM & R : the journal of injury, function, and rehabilitation.

[32]  P. Heerdt,et al.  Impaired systemic oxygen extraction long after mild COVID-19: potential perioperative implications , 2021, British Journal of Anaesthesia.

[33]  P. Thompson,et al.  Diagnosing COVID-19 myocarditis in athletes using cMRI , 2021, Trends in Cardiovascular Medicine.

[34]  Janet Diaz,et al.  A clinical case definition of post-COVID-19 condition by a Delphi consensus , 2021, The Lancet Infectious Diseases.

[35]  P. Ladlow,et al.  Dysautonomia following COVID-19 is not associated with subjective limitations or symptoms but is associated with objective functional limitations , 2021, Heart Rhythm.

[36]  L. Abid,et al.  Long COVID 19 Syndrome: Is It Related to Microcirculation and Endothelial Dysfunction? Insights From TUN-EndCOV Study , 2021, Frontiers in Cardiovascular Medicine.

[37]  T. Robbins,et al.  Hyperbaric oxygen therapy for the treatment of long COVID: early evaluation of a highly promising intervention. , 2021, Clinical medicine.

[38]  P. Tepasse,et al.  Indications of Persistent Glycocalyx Damage in Convalescent COVID-19 Patients: A Prospective Multicenter Study and Hypothesis , 2021, Viruses.

[39]  S. Goland,et al.  Subclinical Myocardial Dysfunction in Patients Recovered from COVID-19 Disease: Correlation with Exercise Capacity , 2021, Biology.

[40]  M. Ståhlberg,et al.  Post-Acute Sequelae of COVID-19 and Cardiovascular Autonomic Dysfunction: What Do We Know? , 2021, Journal of cardiovascular development and disease.

[41]  N. Sverzellati,et al.  Long-Term Cardiac Sequelae in Patients Referred into a Diagnostic Post-COVID-19 Pathway: The Different Impacts on the Right and Left Ventricles , 2021, Diagnostics.

[42]  Deepak L. Bhatt,et al.  Cardiac involvement in the long-term implications of COVID-19 , 2021, Nature Reviews Cardiology.

[43]  J. W. Wassenaar,et al.  Cardiovascular magnetic resonance evaluation of soldiers after recovery from symptomatic SARS-CoV-2 infection: a case–control study of cardiovascular post-acute sequelae of SARS-CoV-2 infection (CV PASC) , 2021, Journal of Cardiovascular Magnetic Resonance.

[44]  H. Schultheiss,et al.  Cardiovascular consequences of viral infections: from COVID to other viral diseases , 2021, Cardiovascular research.

[45]  F. Hakim,et al.  COVID-19 vaccine – Long term immune decline and breakthrough infections , 2021, Vaccine.

[46]  A. Lerman,et al.  In-vivo evidence of systemic endothelial vascular dysfunction in COVID-19 , 2021, International Journal of Cardiology.

[47]  E. Arbustini,et al.  Long COVID: long-term effects? , 2021, European heart journal supplements : journal of the European Society of Cardiology.

[48]  V. Bucciarelli,et al.  Depression pandemic and cardiovascular risk in the COVID-19 era and long COVID syndrome: Gender makes a difference , 2021, Trends in Cardiovascular Medicine.

[49]  P. Kearns,et al.  The immune landscape of SARS-CoV-2-associated Multisystem Inflammatory Syndrome in Children (MIS-C) from acute disease to recovery , 2021, iScience.

[50]  J. Todd,et al.  Identification of LZTFL1 as a candidate effector gene at a COVID-19 risk locus , 2021, Nature Genetics.

[51]  D. Tousoulis,et al.  Cardiovascular disease and COVID-19: a consensus paper from the ESC Working Group on Coronary Pathophysiology & Microcirculation, ESC Working Group on Thrombosis and the Association for Acute CardioVascular Care (ACVC), in collaboration with the European Heart Rhythm Association (EHRA) , 2021, Cardiovascular research.

[52]  R. Eils,et al.  Virus-induced senescence is a driver and therapeutic target in COVID-19 , 2021, Nature.

[53]  S. Solomon,et al.  Recovery of cardiac function following COVID‐19 – ECHOVID‐19: a prospective longitudinal cohort study , 2021, European journal of heart failure.

[54]  S. Yende,et al.  Long COVID and kidney disease , 2021, Nature Reviews Nephrology.

[55]  J. Geddes,et al.  Incidence, co-occurrence, and evolution of long-COVID features: A 6-month retrospective cohort study of 273,618 survivors of COVID-19 , 2021, PLoS medicine.

[56]  Samin K. Sharma,et al.  Types of myocardial injury and mid-term outcomes in patients with COVID-19. , 2021, European heart journal. Quality of care & clinical outcomes.

[57]  A. Schmermund,et al.  Clinical and cardiac magnetic resonance findings in post-COVID patients referred for suspected myocarditis , 2021, Clinical Research in Cardiology.

[58]  C. Kropf-Sanchen,et al.  Long COVID: Distinction between Organ Damage and Deconditioning , 2021, Journal of clinical medicine.

[59]  I. Andreadou,et al.  Association of COVID‐19 with impaired endothelial glycocalyx, vascular function and myocardial deformation 4 months after infection , 2021, European journal of heart failure.

[60]  Md Rezaul Karim,et al.  Clinical Characteristics and the Long-Term Post-recovery Manifestations of the COVID-19 Patients—A Prospective Multicenter Cross-Sectional Study , 2021, Frontiers in Medicine.

[61]  S. Snyder,et al.  Redox imbalance links COVID-19 and myalgic encephalomyelitis/chronic fatigue syndrome , 2021, Proceedings of the National Academy of Sciences.

[62]  P. Manganotti,et al.  Autonomic dysfunction in post-COVID patients with and witfhout neurological symptoms: a prospective multidomain observational study , 2021, Journal of Neurology.

[63]  T. Renné,et al.  Persistent endotheliopathy in the pathogenesis of long COVID syndrome , 2021, Journal of Thrombosis and Haemostasis.

[64]  A. Faron,et al.  Cardiac MRI in Patients with Prolonged Cardiorespiratory Symptoms after Mild to Moderate COVID-19 , 2021, Radiology.

[65]  T. Vos,et al.  Incidence and risk factors for persistent symptoms in adults previously hospitalized for COVID‐19 , 2021, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[66]  S. Piechnik,et al.  Symptom Persistence Despite Improvement in Cardiopulmonary Health – Insights from longitudinal CMR, CPET and lung function testing post-COVID-19 , 2021, EClinicalMedicine.

[67]  W. Niehaus,et al.  Multidisciplinary collaborative consensus guidance statement on the assessment and treatment of fatigue in postacute sequelae of SARS‐CoV‐2 infection (PASC) patients , 2021, PM & R : the journal of injury, function, and rehabilitation.

[68]  S. Wiethoff,et al.  Emerging potential mechanisms and predispositions to the neurological manifestations of COVID-19 , 2021, Journal of the Neurological Sciences.

[69]  G. Pizarro,et al.  Cardiac magnetic resonance in recovering COVID-19 patients. Feature tracking and mapping analysis to detect persistent myocardial involvement , 2021, IJC Heart & Vasculature.

[70]  S. Drakos,et al.  A cardiovascular magnetic resonance imaging-based pilot study to assess coronary microvascular disease in COVID-19 patients , 2021, Scientific Reports.

[71]  M. Ünlü,et al.  Laboratory and Imaging Evaluation of Cardiac Involvement in Patients with Post-Acute COVID-19 , 2021, International journal of general medicine.

[72]  Suhua Zhou,et al.  Serum nitrite and nitrate: A potential biomarker for post-covid-19 complications? , 2021, Free Radical Biology and Medicine.

[73]  N. Schiefermeier-Mach,et al.  Post-COVID-19 Rehabilitation: Perception and Experience of Austrian Physiotherapists and Physiotherapy Students , 2021, International journal of environmental research and public health.

[74]  I. Pavord,et al.  Risk Predictors and Symptom Features of Long COVID Within a Broad Primary Care Patient Population Including Both Tested and Untested Patients , 2021, Pragmatic and observational research.

[75]  L. Schomburg Selenium Deficiency Due to Diet, Pregnancy, Severe Illness, or COVID-19—A Preventable Trigger for Autoimmune Disease , 2021, International journal of molecular sciences.

[76]  M. Maniscalco,et al.  Persistent Endothelial Dysfunction in Post-Acute COVID-19 Syndrome: A Case-Control Study , 2021, Biomedicines.

[77]  P. Edison,et al.  Long covid—mechanisms, risk factors, and management , 2021, BMJ.

[78]  F. Dioguardi,et al.  Serum Metabolic Profile in Patients With Long-Covid (PASC) Syndrome: Clinical Implications , 2021, Frontiers in Medicine.

[79]  K. Roe A role for T‐cell exhaustion in Long COVID‐19 and severe outcomes for several categories of COVID‐19 patients , 2021, Journal of neuroscience research.

[80]  A. Allegretti,et al.  Acute Kidney Injury Incidence, Recovery, and Long-term Kidney Outcomes Among Hospitalized Patients With COVID-19 and Influenza , 2021, Kidney International Reports.

[81]  R. Guner,et al.  Post‐COVID syndrome: A single‐center questionnaire study on 1007 participants recovered from COVID‐19 , 2021, Journal of medical virology.

[82]  Mattia G. Bergomi,et al.  Mapping the human genetic architecture of COVID-19 , 2021, Nature.

[83]  L. Walton,et al.  Prevalence of Long COVID symptoms in Bangladesh: a prospective Inception Cohort Study of COVID-19 survivors , 2021, BMJ Global Health.

[84]  Chen-Yu Zhang,et al.  A virus-derived microRNA-like small RNA serves as a serum biomarker to prioritize the COVID-19 patients at high risk of developing severe disease , 2021, Cell discovery.

[85]  A. Lucendo,et al.  Long-Term Outcomes of Patients with Coronavirus Disease 2019 at One Year after Hospital Discharge , 2021, Journal of clinical medicine.

[86]  D. Kobak,et al.  Tracking excess mortality across countries during the COVID-19 pandemic with the World Mortality Dataset , 2021, eLife.

[87]  F. Koehler,et al.  Late phase of COVID‐19 pandemic in General Cardiology. A position paper of the ESC Council for Cardiology Practice , 2021, ESC heart failure.

[88]  R. V. Vander Heide,et al.  COVID-19 myocarditis: quantitative analysis of the inflammatory infiltrate and a proposed mechanism , 2021, Cardiovascular Pathology.

[89]  H. Bartsch,et al.  Long COVID in a prospective cohort of home-isolated patients , 2021, Nature Medicine.

[90]  K. Meyer,et al.  SARS-CoV-2 Spike Protein Induces Paracrine Senescence and Leukocyte Adhesion in Endothelial Cells , 2021, Journal of virology.

[91]  A. Della Corte,et al.  Cardiac sequelae after coronavirus disease 2019 recovery: a systematic review , 2021, Clinical Microbiology and Infection.

[92]  P. Goepfert,et al.  Duration of post–COVID-19 symptoms is associated with sustained SARS-CoV-2–specific immune responses , 2021, JCI insight.

[93]  H. Bøtker,et al.  COVID-19 related cardiac complications - from clinical evidences to basic mechanisms. Opinion paper of the ESC Working Group on Cellular Biology of the Heart. , 2021, Cardiovascular research.

[94]  N. LeBrasseur,et al.  Senolytics reduce coronavirus-related mortality in old mice , 2021, Science.

[95]  P. Richardson,et al.  Is the Endothelium the Missing Link in the Pathophysiology and Treatment of COVID-19 Complications? , 2021, Cardiovascular Drugs and Therapy.

[96]  A. Ducharme,et al.  Long COVID-19: A Primer for Cardiovascular Health Professionals, on Behalf of the CCS Rapid Response Team , 2021, Canadian Journal of Cardiology.

[97]  M. Drayson,et al.  Establishing the prevalence of common tissue‐specific autoantibodies following severe acute respiratory syndrome coronavirus 2 infection , 2021, Clinical and experimental immunology.

[98]  I. Al Busaidi,et al.  Late-Onset COVID-19-Related Multi-System Inflammatory Syndrome in a Middle-Aged Man , 2021, Cureus.

[99]  S. Scalvini,et al.  Altered Vascular Endothelium-Dependent Responsiveness in Frail Elderly Patients Recovering from COVID-19 Pneumonia: Preliminary Evidence , 2021, Journal of clinical medicine.

[100]  C. Giurgi-Oncu,et al.  Associations between the Severity of the Post-Acute COVID-19 Syndrome and Echocardiographic Abnormalities in Previously Healthy Outpatients Following Infection with SARS-CoV-2 , 2021, Biology.

[101]  N. Maskell,et al.  Symptoms After COVID-19 Vaccination in Patients With Persistent Symptoms After Acute Infection: A Case Series , 2021, Annals of Internal Medicine.

[102]  S. Yong Long COVID or post-COVID-19 syndrome: putative pathophysiology, risk factors, and treatments , 2021, Infectious diseases.

[103]  M. Spraul,et al.  Incomplete Systemic Recovery and Metabolic Phenoreversion in Post-Acute-Phase Nonhospitalized COVID-19 Patients: Implications for Assessment of Post-Acute COVID-19 Syndrome , 2021, Journal of proteome research.

[104]  S. Rosenkranz,et al.  Post-COVID syndrome in non-hospitalised patients with COVID-19: a longitudinal prospective cohort study , 2021, The Lancet Regional Health - Europe.

[105]  F. Schuch,et al.  Circulating Type I Interferon Levels and COVID-19 Severity: A Systematic Review and Meta-Analysis , 2021, Frontiers in Immunology.

[106]  Henrik Nielsen,et al.  Post-acute effects of SARS-CoV-2 infection in individuals not requiring hospital admission: a Danish population-based cohort study , 2021, The Lancet Infectious Diseases.

[107]  N. Murillo,et al.  What's going on following acute covid-19? Clinical characteristics of patients in an out-patient rehabilitation program. , 2021, NeuroRehabilitation.

[108]  P. Kellman,et al.  Prospective Case-Control Study of Cardiovascular Abnormalities 6 Months Following Mild COVID-19 in Healthcare Workers , 2021, JACC: Cardiovascular Imaging.

[109]  J. Arano Llach,et al.  Inappropriate sinus tachycardia in post-covid-19 Syndrome , 2021, Europace.

[110]  B. E. Fan,et al.  ST-segment elevation myocardial infarction in post-COVID-19 patients: A case series. , 2021, Annals of the Academy of Medicine, Singapore.

[111]  J. Courel-Ibáñez,et al.  Post-COVID-19 Syndrome and the Potential Benefits of Exercise , 2021, International journal of environmental research and public health.

[112]  G. Wright,et al.  Suspected subclinical myocarditis detected by cardiac magnetic resonance imaging late post COVID-19 recovery , 2021, Journal of Cardiology Cases.

[113]  F. Mentré,et al.  Persistent COVID-19 symptoms are highly prevalent 6 months after hospitalization: results from a large prospective cohort , 2021, Clinical Microbiology and Infection.

[114]  V. Marx Scientists set out to connect the dots on long COVID , 2021, Nature Methods.

[115]  M. L. La Rovere,et al.  Evidence for Biological Age Acceleration and Telomere Shortening in COVID-19 Survivors , 2021, medRxiv.

[116]  S. Walker,et al.  Patient symptoms and experience following COVID-19: results from a UK-wide survey , 2021, BMJ Open Respiratory Research.

[117]  Manesh R. Patel,et al.  SARS-CoV-2 Cardiac Involvement in Young Competitive Athletes , 2021, Circulation.

[118]  E. Benarroch,et al.  Autonomic dysfunction following COVID-19 infection: an early experience , 2021, Clinical Autonomic Research.

[119]  P. Ferdinandy,et al.  Cardiovascular RNA markers and artificial intelligence may improve COVID-19 outcome: a position paper from the EU-CardioRNA COST Action CA17129 , 2021, Cardiovascular research.

[120]  M. Tobin-D'Angelo,et al.  Trends in Geographic and Temporal Distribution of US Children With Multisystem Inflammatory Syndrome During the COVID-19 Pandemic. , 2021, JAMA pediatrics.

[121]  Paul J. Harrison,et al.  6-month neurological and psychiatric outcomes in 236 379 survivors of COVID-19: a retrospective cohort study using electronic health records , 2021, The Lancet Psychiatry.

[122]  K. Kraft,et al.  Feasibility of Vitamin C in the Treatment of Post Viral Fatigue with Focus on Long COVID, Based on a Systematic Review of IV Vitamin C on Fatigue , 2021, Nutrients.

[123]  A. Banerjee,et al.  Post-covid syndrome in individuals admitted to hospital with covid-19: retrospective cohort study , 2021, BMJ.

[124]  R. Anderson,et al.  The Leading Causes of Death in the US for 2020. , 2021, JAMA.

[125]  I. Torjesen Covid-19: Middle aged women face greater risk of debilitating long term symptoms , 2021, BMJ.

[126]  W. Lim,et al.  Long Covid in adults discharged from UK hospitals after Covid-19: A prospective, multicentre cohort study using the ISARIC WHO Clinical Characterisation Protocol , 2021, The Lancet Regional Health - Europe.

[127]  D. Brodie,et al.  Post-acute COVID-19 syndrome , 2021, Nature Medicine.

[128]  M. Banach,et al.  COVID-19 and cardiovascular complications – preliminary results of the LATE-COVID study , 2021, Archives of medical science : AMS.

[129]  L. Cooper,et al.  What we (don’t) know about myocardial injury after COVID-19 , 2021, European heart journal.

[130]  C. Castilletti,et al.  Human cardiosphere-derived stromal cells exposed to SARS-CoV-2 evolve into hyper-inflammatory/pro-fibrotic phenotype and produce infective viral particles depending on the levels of ACE2 receptor expression , 2021, Cardiovascular research.

[131]  David A. Drew,et al.  Attributes and predictors of long COVID , 2021, Nature Medicine.

[132]  C. Bunker,et al.  Chilblain-like acral lesions in long COVID-19: management and implications for understanding microangiopathy , 2021, The Lancet Infectious Diseases.

[133]  M. Cecconi,et al.  Long COVID hallmarks on [18F]FDG-PET/CT: a case-control study , 2021, European Journal of Nuclear Medicine and Molecular Imaging.

[134]  M. Brady,et al.  Multiorgan impairment in low-risk individuals with post-COVID-19 syndrome: a prospective, community-based study , 2021, BMJ Open.

[135]  D. Girelli,et al.  Importance of Cardiopulmonary Exercise Testing amongst Subjects Recovering from COVID-19 , 2021, Diagnostics.

[136]  M. Ciccarelli,et al.  Exercise Training and Cardiac Rehabilitation in COVID-19 Patients with Cardiovascular Complications: State of Art , 2021, Life.

[137]  Q. Ning,et al.  Long-term micro-structure and cerebral blood flow changes in patients recovered from COVID-19 without neurological manifestations. , 2021, The Journal of clinical investigation.

[138]  R. Kumar,et al.  COVID-19 related multisystem inflammatory syndrome in children (MIS-C): Role of 18F-FDG PET/CT to assess myocardial involvement , 2021, Journal of Nuclear Cardiology.

[139]  S. Kesari,et al.  A Review of Persistent Post-COVID Syndrome (PPCS) , 2021, Clinical Reviews in Allergy & Immunology.

[140]  P. Kellman,et al.  Patterns of myocardial injury in recovered troponin-positive COVID-19 patients assessed by cardiovascular magnetic resonance , 2021, European heart journal.

[141]  G. Stefano Historical Insight into Infections and Disorders Associated with Neurological and Psychiatric Sequelae Similar to Long COVID , 2021, Medical science monitor : international medical journal of experimental and clinical research.

[142]  I. Martín-Loeches,et al.  Prolonged elevation of D‐dimer levels in convalescent COVID‐19 patients is independent of the acute phase response , 2021, Journal of Thrombosis and Haemostasis.

[143]  J. Guck,et al.  Physical phenotype of blood cells is altered in COVID-19 , 2021, bioRxiv.

[144]  A. Movila,et al.  Age-dependent effects of the recombinant spike protein/SARS-CoV-2 on the M–CSF– and IL-34-differentiated macrophages in vitro , 2021, Biochemical and Biophysical Research Communications.

[145]  A. West,et al.  Identifying patients at risk of post-discharge complications related to COVID-19 infection , 2021, Thorax.

[146]  R. Steeds,et al.  Persisting Adverse Ventricular Remodeling in COVID-19 Survivors: A Longitudinal Echocardiographic Study , 2021, Journal of the American Society of Echocardiography.

[147]  L. Østergaard SARS CoV‐2 related microvascular damage and symptoms during and after COVID‐19: Consequences of capillary transit‐time changes, tissue hypoxia and inflammation , 2021, Physiological reports.

[148]  E. Wherry,et al.  New-Onset IgG Autoantibodies in Hospitalized Patients with COVID-19 , 2021, medRxiv.

[149]  John P. Moore,et al.  SARS-CoV-2 Vaccines and the Growing Threat of Viral Variants. , 2021, JAMA.

[150]  M. Feltkamp,et al.  Short-term outpatient follow-up of COVID-19 patients: A multidisciplinary approach , 2021, EClinicalMedicine.

[151]  Silamlak Birhanu Abegaz Human ABO Blood Groups and Their Associations with Different Diseases , 2021, BioMed research international.

[152]  C. Catena,et al.  Short-term cardiac outcome in survivors of COVID-19: a systematic study after hospital discharge , 2021, Clinical Research in Cardiology.

[153]  G. Erbaş,et al.  The assessment of serum ACE activity in COVID-19 and its association with clinical features and severity of the disease , 2021, Scandinavian journal of clinical and laboratory investigation.

[154]  S. Villapol,et al.  More than 50 long-term effects of COVID-19: a systematic review and meta-analysis , 2021, Scientific Reports.

[155]  W. Drygas,et al.  Cardiac involvement in consecutive elite athletes recovered from Covid‐19: A magnetic resonance study , 2021, Journal of magnetic resonance imaging : JMRI.

[156]  A. Bellasi,et al.  Surviving COVID-19 in Bergamo province: a post-acute outpatient re-evaluation , 2021, Epidemiology and Infection.

[157]  S. Goldbarg,et al.  Assessment of thirty‐day readmission rate, timing, causes and predictors after hospitalization with COVID‐19 , 2021, Journal of internal medicine.

[158]  M. Andrés,et al.  Post-acute COVID-19 syndrome. Incidence and risk factors: A Mediterranean cohort study , 2021, Journal of Infection.

[159]  M. Blasco,et al.  Shorter telomere lengths in patients with severe COVID-19 disease , 2021, Aging.

[160]  T. Welte,et al.  Circulating cardiovascular microRNAs in critically ill COVID‐19 patients , 2021, European journal of heart failure.

[161]  Asimina Dominari,et al.  Cardio-Pulmonary Sequelae in Recovered COVID-19 Patients: Considerations for Primary Care , 2021, Journal of primary care & community health.

[162]  Guohui Fan,et al.  RETRACTED: 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study , 2021, The Lancet.

[163]  Helio T. Navarro,et al.  Circuits between infected macrophages and T cells in SARS-CoV-2 pneumonia , 2020, Nature.

[164]  M. Jenkinson,et al.  Medium-term effects of SARS-CoV-2 infection on multiple vital organs, exercise capacity, cognition, quality of life and mental health, post-hospital discharge , 2020, EClinicalMedicine.

[165]  S. Kent,et al.  Plasma ACE2 activity is persistently elevated following SARS-CoV-2 infection: implications for COVID-19 pathogenesis and consequences , 2020, European Respiratory Journal.

[166]  Persistence of Antibody and Cellular Immune Responses in Coronavirus Disease 2019 Patients Over Nine Months After Infection , 2021 .

[167]  A. Perotte,et al.  High rate of renal recovery in survivors of COVID-19 associated acute renal failure requiring renal replacement therapy , 2020, PloS one.

[168]  T. Hobman,et al.  Endothelium Infection and Dysregulation by SARS-CoV-2: Evidence and Caveats in COVID-19 , 2020, Viruses.

[169]  J. Guevara-Coto,et al.  Immune-Based Prediction of COVID-19 Severity and Chronicity Decoded Using Machine Learning , 2020, bioRxiv.

[170]  F. Kronenberg,et al.  Cardiopulmonary recovery after COVID-19: an observational prospective multicentre trial , 2020, European Respiratory Journal.

[171]  E. Sorbets,et al.  Clinical, virological and imaging profile in patients with prolonged forms of COVID-19: A cross-sectional study , 2020, Journal of Infection.

[172]  N. Mackman,et al.  Circulating Markers of Neutrophil Extracellular Traps Are of Prognostic Value in Patients With COVID-19 , 2020, Arteriosclerosis, thrombosis, and vascular biology.

[173]  R. Sutton,et al.  Autonomic dysfunction in 'long COVID': rationale, physiology and management strategies. , 2020, Clinical medicine.

[174]  E. Wood,et al.  Role of mitochondria, oxidative stress and the response to antioxidants in myalgic encephalomyelitis/chronic fatigue syndrome: A possible approach to SARS-CoV-2 ‘long-haulers’? , 2020, Chronic Diseases and Translational Medicine.

[175]  W. Heywood,et al.  'The long tail of Covid-19' - The detection of a prolonged inflammatory response after a SARS-CoV-2 infection in asymptomatic and mildly affected patients. , 2020, F1000Research.

[176]  L. Rénia,et al.  Convalescent COVID-19 patients are susceptible to endothelial dysfunction due to persistent immune activation , 2020, medRxiv.

[177]  V. Chopra,et al.  Sixty-Day Outcomes Among Patients Hospitalized With COVID-19 , 2020, Annals of Internal Medicine.

[178]  S. Vasoo,et al.  Delayed catastrophic thrombotic events in young and asymptomatic post COVID-19 patients , 2020, Journal of Thrombosis and Thrombolysis.

[179]  M. Diamond,et al.  SARS-CoV-2 Infects Human Engineered Heart Tissues and Models COVID-19 Myocarditis , 2020, bioRxiv.

[180]  M. Nussenzweig,et al.  Evolution of Antibody Immunity to SARS-CoV-2 , 2020, bioRxiv.

[181]  A. Alsheikh-Ali,et al.  Molecular Basis of Cardiac and Vascular Injuries Associated With COVID-19 , 2020, Frontiers in Cardiovascular Medicine.

[182]  Jeremy S. Brown,et al.  ‘Long-COVID’: a cross-sectional study of persisting symptoms, biomarker and imaging abnormalities following hospitalisation for COVID-19 , 2020, Thorax.

[183]  A. Haberland,et al.  Aptamer BC 007 - Efficient binder of spreading-crucial SARS-CoV-2 proteins , 2020, Heliyon.

[184]  M. Cecconi,et al.  Vasculitis changes in COVID-19 survivors with persistent symptoms: an [18F]FDG-PET/CT study , 2020, European Journal of Nuclear Medicine and Molecular Imaging.

[185]  A. Cohen-Solal,et al.  Delayed acute myocarditis and COVID‐19‐related multisystem inflammatory syndrome , 2020, ESC heart failure.

[186]  P. Laterre,et al.  Short telomeres increase the risk of severe COVID-19 , 2020, Aging.

[187]  K. Kurz,et al.  Persisting alterations of iron homeostasis in COVID-19 are associated with non-resolving lung pathologies and poor patients’ performance: a prospective observational cohort study , 2020, Respiratory Research.

[188]  N. Marx,et al.  Follow up of patients with severe coronavirus disease 2019 (COVID-19): Pulmonary and extrapulmonary disease sequelae , 2020, Respiratory Medicine.

[189]  K. Peter,et al.  Higher mortality of COVID-19 in males: sex differences in immune response and cardiovascular comorbidities , 2020, Cardiovascular research.

[190]  M. Honigsbaum,et al.  Taking pandemic sequelae seriously: from the Russian influenza to COVID-19 long-haulers , 2020, The Lancet.

[191]  F. Bruyère,et al.  Follow-up of adults with noncritical COVID-19 two months after symptom onset , 2020, Clinical Microbiology and Infection.

[192]  M. Spruit,et al.  Persistent symptoms 3 months after a SARS-CoV-2 infection: the post-COVID-19 syndrome? , 2020, ERJ Open Research.

[193]  Haitham Saeed,et al.  Assessment and characterisation of post‐COVID‐19 manifestations , 2020, International journal of clinical practice.

[194]  L. Hensley,et al.  How NETosis could drive “Post-COVID-19 syndrome” among survivors , 2020, Immunology Letters.

[195]  M. H. Cheng,et al.  Superantigenic character of an insert unique to SARS-CoV-2 spike supported by skewed TCR repertoire in patients with hyperinflammation , 2020, Proceedings of the National Academy of Sciences.

[196]  Barbara B. Shih,et al.  Genetic mechanisms of critical illness in COVID-19 , 2020, Nature.

[197]  Steven M. Holland,et al.  Autoantibodies against type I IFNs in patients with life-threatening COVID-19 , 2020, Science.

[198]  Jacques Fellay,et al.  Inborn errors of type I IFN immunity in patients with life-threatening COVID-19 , 2020, Science.

[199]  Jiao Li,et al.  Clinical sequelae of COVID-19 survivors in Wuhan, China: a single-centre longitudinal study , 2020, Clinical Microbiology and Infection.

[200]  M. Borghesan,et al.  Cellular senescence as a potential mediator of COVID‐19 severity in the elderly , 2020, Aging cell.

[201]  L. Weinstock,et al.  Covid-19 hyperinflammation and post-Covid-19 illness may be rooted in mast cell activation syndrome , 2020, International Journal of Infectious Diseases.

[202]  B. Fantin,et al.  Post-discharge persistent symptoms and health-related quality of life after hospitalization for COVID-19 , 2020, Journal of Infection.

[203]  K. Wilson,et al.  COVID-19 and multisystem inflammatory syndrome in children and adolescents , 2020, The Lancet Infectious Diseases.

[204]  J. Mason,et al.  A dynamic COVID-19 immune signature includes associations with poor prognosis , 2020, Nature Medicine.

[205]  N. Maskell,et al.  Patient outcomes after hospitalisation with COVID-19 and implications for follow-up; results from a prospective UK cohort. , 2020, medRxiv.

[206]  T. Greenhalgh,et al.  Management of post-acute covid-19 in primary care , 2020, BMJ.

[207]  C. Weber,et al.  Endothelial dysfunction in COVID-19: a position paper of the ESC Working Group for Atherosclerosis and Vascular Biology, and the ESC Council of Basic Cardiovascular Science , 2020, Cardiovascular research.

[208]  Jay S. Steingrub,et al.  Symptom Duration and Risk Factors for Delayed Return to Usual Health Among Outpatients with COVID-19 in a Multistate Health Care Systems Network — United States, March–June 2020 , 2020, MMWR. Morbidity and mortality weekly report.

[209]  Manoj Sivan,et al.  Postdischarge symptoms and rehabilitation needs in survivors of COVID‐19 infection: A cross‐sectional evaluation , 2020, Journal of medical virology.

[210]  J. Dowds,et al.  Persistent fatigue following SARS-CoV-2 infection is common and independent of severity of initial infection , 2020, medRxiv.

[211]  P. Kirchhof,et al.  Association of Cardiac Infection With SARS-CoV-2 in Confirmed COVID-19 Autopsy Cases. , 2020, JAMA cardiology.

[212]  Eike Nagel,et al.  Outcomes of Cardiovascular Magnetic Resonance Imaging in Patients Recently Recovered From Coronavirus Disease 2019 (COVID-19) , 2020, JAMA cardiology.

[213]  Yanfeng Gao,et al.  Follow-up study of the pulmonary function and related physiological characteristics of COVID-19 survivors three months after recovery , 2020, EClinicalMedicine.

[214]  Angelo Carfì,et al.  Persistent Symptoms in Patients After Acute COVID-19. , 2020, JAMA.

[215]  P. Buehler,et al.  Evidence for structural protein damage and membrane lipid remodeling in red blood cells from COVID-19 patients , 2020, medRxiv.

[216]  N. Narula,et al.  Cardiology Practice and Training Post-COVID-19 , 2020, Journal of the American College of Cardiology.

[217]  M. Dweck,et al.  Global evaluation of echocardiography in patients with COVID-19 , 2020, European heart journal cardiovascular Imaging.

[218]  J. Erdmann,et al.  Genomewide Association Study of Severe Covid-19 with Respiratory Failure , 2020, The New England journal of medicine.

[219]  M. Blagosklonny From causes of aging to death from COVID-19 , 2020, Aging.

[220]  P. Davies,et al.  Clinical Characteristics of 58 Children With a Pediatric Inflammatory Multisystem Syndrome Temporally Associated With SARS-CoV-2. , 2020, JAMA.

[221]  A. Frangakis,et al.  SARS-CoV-2 infects and induces cytotoxic effects in human cardiomyocytes , 2020, bioRxiv.

[222]  C. Page,et al.  Animal models of mechanisms of SARS‐CoV‐2 infection and COVID‐19 pathology , 2020, British journal of pharmacology.

[223]  Hesong Zeng,et al.  Cardiac Involvement in Patients Recovered From COVID-2019 Identified Using Magnetic Resonance Imaging , 2020, JACC: Cardiovascular Imaging.

[224]  V. Bansal,et al.  A single-cell RNA expression map of human coronavirus entry factors , 2020, bioRxiv.

[225]  M. Girardis,et al.  Marked T cell activation, senescence, exhaustion and skewing towards TH17 in patients with COVID-19 pneumonia , 2020, Nature Communications.

[226]  Tao Guo,et al.  Cardiovascular Implications of Fatal Outcomes of Patients With Coronavirus Disease 2019 (COVID-19) , 2020, JAMA cardiology.

[227]  Z. Tian,et al.  Functional exhaustion of antiviral lymphocytes in COVID-19 patients , 2020, Cellular & Molecular Immunology.

[228]  Yong-tang Zheng,et al.  Elevated exhaustion levels and reduced functional diversity of T cells in peripheral blood may predict severe progression in COVID-19 patients , 2020, Cellular & Molecular Immunology.

[229]  Fenglian Ma,et al.  Coronavirus fulminant myocarditis treated with glucocorticoid and human immunoglobulin , 2020, European heart journal.

[230]  Qian Zhang Human genetics of life-threatening influenza pneumonitis , 2020, Human Genetics.

[231]  M. A. Said,et al.  Genetically Determined ABO Blood Group and its Associations With Health and Disease , 2020, Arteriosclerosis, thrombosis, and vascular biology.

[232]  Steve Horvath,et al.  DNA methylation-based biomarkers and the epigenetic clock theory of ageing , 2018, Nature Reviews Genetics.

[233]  Y. Li,et al.  Altered Lipid Metabolism in Recovered SARS Patients Twelve Years after Infection , 2017, Scientific Reports.

[234]  Tobias Jung,et al.  Happily (n)ever after: Aging in the context of oxidative stress, proteostasis loss and cellular senescence , 2016, Redox biology.

[235]  L. Cooper,et al.  Imaging of Inflammation in Unexplained Cardiomyopathy. , 2016, JACC. Cardiovascular imaging.